phase 1_completion
saveBoehringer Ingelheim International GmbH — BI-765179 (Phase I Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Cervical Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Esophageal Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Gastric Cancer, Head And Neck Cancer, Head And Neck Squamous Cell Carcinoma (HNSC), Hepatocellular Carcinoma, Hypopharyngeal Cancer, Laryngeal Cancer, Malignant Pleural Mesothelioma, Melanoma, Non-Small Cell Lung Carcinoma, Oral Cancer, Oral Cavity (Mouth) Cancer, Oropharyngeal Cancer, Ovarian Cancer, Pancreatic Cancer, Re
Data sources
globaldata
Found something off?
🐶 often sniffed alongside
top 7- tagOncology13 co-mentions · 1 sources
- tagSmall Molecule2 co-mentions · 1 sources
- companyBoehringer Ingelheim International GmbH1 co-mentions · 1 sources
- companyBoehringer Ingelheim Corp1 co-mentions · 1 sources
- tagPulmonology1 co-mentions · 1 sources
- tagColorectal Cancer1 co-mentions · 1 sources
- tagMelanoma1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that